Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post-bone marrow transplant patient management.

C M Poliquin1

  • 1Jean Marie Colbert Bone Marrow Transplant Center, University of Connecticut Health Center, Farmington.

The Yale Journal of Biology and Medicine
|September 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overview of bone marrow and peripheral blood stem cell transplantation.

Clinical journal of oncology nursing·1997
See all related articles

Bone marrow transplant (BMT) is a vital treatment for hematologic diseases but carries significant risks. Understanding and managing complications like infections and graft-versus-host disease is crucial for patient recovery and long-term care.

Area of Science:

  • Hematology
  • Transplant Medicine
  • Oncology

Background:

  • Bone marrow transplant (BMT) is increasingly utilized for hematologic diseases.
  • BMT is associated with numerous potentially severe complications.
  • Complications arise from both the conditioning regimen and the engrafted marrow.

Purpose of the Study:

  • To outline the common complications following bone marrow transplantation.
  • To describe the timeline of engraftment and patient discharge.
  • To emphasize the importance of post-transplant follow-up care.

Main Methods:

  • Review of established complications associated with bone marrow transplantation.
  • Description of conditioning regimen-induced toxicities (neutropenia, thrombocytopenia, VOD).

Related Experiment Videos

  • Explanation of graft-versus-host disease in allogeneic BMT.

    • Main Results:

    • Conditioning regimens can lead to neutropenia, thrombocytopenia, infection, bleeding, and mucositis.
    • Chemotherapy-induced hepatotoxicity (VOD) can cause liver disease.
    • Graft-versus-host disease is a common complication of allogeneic BMT.
    • Engraftment typically appears 14-28 days post-transplant.
    • Patients are discharged when specific criteria are met.
    • Follow-up care extends for approximately one year.

    Conclusions:

    • BMT is a complex procedure with significant risks that require careful management.
    • Post-transplant monitoring is essential for addressing complications and ensuring patient recovery.
    • Long-term follow-up care is critical for patients undergoing bone marrow transplantation.